{"id":388,"date":"2024-08-14T19:48:14","date_gmt":"2024-08-14T19:48:14","guid":{"rendered":"https:\/\/scott-carrington.com\/?p=388"},"modified":"2024-08-21T16:28:34","modified_gmt":"2024-08-21T16:28:34","slug":"how-many-people-with-employer-sponsored-insurance-use-the-drugs-slated-for-medicare-price-negotiations","status":"publish","type":"post","link":"https:\/\/scott-carrington.com\/index.php\/2024\/08\/14\/how-many-people-with-employer-sponsored-insurance-use-the-drugs-slated-for-medicare-price-negotiations\/","title":{"rendered":"How many people with employer-sponsored insurance use the drugs slated for Medicare price negotiations"},"content":{"rendered":"<p>A new KFF analysis examines the number of enrollees in the employer-sponsored insurance market who use one or more of the ten drugs selected for Medicare Part D price negotiations. Among the 167 million people with employer-sponsored insurance in 2022, 3.4 million used at least one of the 10 drugs. The analysis is available on<span class=\"readmore-ellipsis\">&#8230;<\/span><a href=\"https:\/\/www.kff.org\/health-costs\/issue-brief\/how-many-people-with-employer-sponsored-insurance-use-the-drugs-slated-for-medicare-price-negotiations\/\" class=\"see-more light-beige no-float inline-readmore\">More<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>A new KFF analysis examines the number of enrollees in the employer-sponsored insurance market who use one or more of<\/p>\n","protected":false},"author":1,"featured_media":390,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":[],"categories":[12],"tags":[],"_links":{"self":[{"href":"https:\/\/scott-carrington.com\/index.php\/wp-json\/wp\/v2\/posts\/388"}],"collection":[{"href":"https:\/\/scott-carrington.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/scott-carrington.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/scott-carrington.com\/index.php\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/scott-carrington.com\/index.php\/wp-json\/wp\/v2\/comments?post=388"}],"version-history":[{"count":1,"href":"https:\/\/scott-carrington.com\/index.php\/wp-json\/wp\/v2\/posts\/388\/revisions"}],"predecessor-version":[{"id":389,"href":"https:\/\/scott-carrington.com\/index.php\/wp-json\/wp\/v2\/posts\/388\/revisions\/389"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/scott-carrington.com\/index.php\/wp-json\/wp\/v2\/media\/390"}],"wp:attachment":[{"href":"https:\/\/scott-carrington.com\/index.php\/wp-json\/wp\/v2\/media?parent=388"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/scott-carrington.com\/index.php\/wp-json\/wp\/v2\/categories?post=388"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/scott-carrington.com\/index.php\/wp-json\/wp\/v2\/tags?post=388"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}